Between evidence and commerce - the case of sufentanil sublingual tablet systems
File(s)
Published version
Author(s)
Bantel, C
Laycock, HC
Type
Journal Article
Date Issued
2017-12-08
Date Acceptance
2017-08-01
Citation
Anaesthesia, 2017, 73 (2), pp.143-147
ISSN
0003-2409
Publisher
Wiley
Start Page
143
End Page
147
Journal / Book Title
Anaesthesia
Volume
73
Issue
2
Copyright Statement
© 2017 The Authors. Anaesthesia published by John Wiley & Sons Ltd on behalf of Association of Anaesthetists of Great Britain and Ireland.
This is an open access article under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made.
This is an open access article under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made.
Identifier
http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000419871300001&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=1ba7043ffcc86c417c072aa74d649202
Subjects
Science & Technology
Life Sciences & Biomedicine
Anesthesiology
conflict of interest
pain
sublingual sufentanil
CONFLICTS-OF-INTEREST
POSTOPERATIVE PAIN
CONTROLLED-TRIALS
DATA FABRICATION
FAKE JOURNALS
MANAGEMENT
DISCLOSURES
QUALITY
Publication Status
Published